Professor, Camilo Jose Cela University
Francisco Lopez-Munoz studied Medicine at Complutense University (Madrid). He received his PhD Degree in Medicine at Complutense University in 1993, with a Thesis on postnatal development of the rat pineal gland after chemical denervation that won the Doctorate Extraordinary Award. During her pre- and post-doctoral training, he worked in neurohistology at the Department of Cellular Biology of the Complutense University. He is specialist in Pharmaceutical Medicine. Between 1992 and 2009, he worked in the pharmaceutical industry (Juste, S.A.Q.F.), as Medical Director. After 1996 he is honorary research Professor at the Pharmacology Department of the University of Alcala, working primarily in the field of neuropsychopharmacology. Currently, he is Professor of Pharmacology at Camilo Jose Cela University (Madrid). Dr. Lopez-Munoz is editor/author of 14 books, highlighting its History of Psychopharmacology (3 volumes; Editorial Medica Panamericana, 2007), and Neurobiology of Depression (Taylor & Francis Group LLC, in press), and 138 chapters of books related to the psychopharmacology. He has published 105 papers on indexed journals with impact factor and 163 in Spanish journals. He has participated in 108 scientific meetings, and is member of many scientific societies (including Collegium Internationale Neuro-Psychopharmacologicum) and editorial boards, including European Journal of Pharmacology and Frontiers in Psychopharmacology. Dr. Lopez-Munoz has participated, as visiting Professor and Director, in postgraduate and doctorate courses from different Spanish academic centres.
His main research lines have been the postnatal development of mammals pineal gland after chemical sympathectomy, the biological bases of drug abuse and dual diagnosis, the psychotropic drugs interactions, the neurobiology of aggressivity, the bibliometric techniques applied to mental health-related disciplines and neuropsychopharmacology, the combination therapies with antidepressant drugs in resistant depression and with antipsychotics drugs in patients with refractory schizophrenia, and the history of the psychopharmacology.